Source: European Journal of Pain. Unidade: FMRP
Subjects: BLOQUEADORES NEUROMUSCULARES, ANGIOTENSINA II, BRADICININA, GENÉTICA
ABNT
ZANATA, Graziele C.; OLIVEIRA, Francisco Fábio Bezerra; SCHIVO, Ieda Regina dos Santos; et al. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice. European Journal of Pain, Oxford, v. 25, n. 1, p. 189-198, 2021. Disponível em: < https://doi.org/10.1002/ejp.1660 > DOI: 10.1002/ejp.1660.APA
Zanata, G. C., Oliveira, F. F. B., Schivo, I. R. dos S., Cunha, F. de Q., McNaughton, P., Cunha, T. M., et al. (2021). Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice. European Journal of Pain, 25( 1), 189-198. doi:10.1002/ejp.1660NLM
Zanata GC, Oliveira FFB, Schivo IR dos S, Cunha F de Q, McNaughton P, Cunha TM, Silva RL, Pinto LG, Silva NR da, Lopes AHP. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice [Internet]. European Journal of Pain. 2021 ; 25( 1): 189-198.Available from: https://doi.org/10.1002/ejp.1660Vancouver
Zanata GC, Oliveira FFB, Schivo IR dos S, Cunha F de Q, McNaughton P, Cunha TM, Silva RL, Pinto LG, Silva NR da, Lopes AHP. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice [Internet]. European Journal of Pain. 2021 ; 25( 1): 189-198.Available from: https://doi.org/10.1002/ejp.1660